Effect of Vitamin D on Paraxonase-1, Total Antioxidant Capacity, and 8-Isoprostan in Children with Attention Deficit Hyperactivity Disorder

Table 3

Comparison of dietary intake between treatment and placebo groups at the beginning of the study.

Variable per day (%)	Placebo control	Vitamin D	value
Energy (kcal)	1822.84 (32.83)	1835.13 (61.35)	0.85
CHO (g)	231.42 (6.35)	276.10 (36.01)	0.22
PRO (g)	55.11 (2.14)	58.77 (2.699)	0.29
FAT (g)	78.32 (2.31)	78.57 (2.79)	0.94
Vitamin E (mg/L)	23.05 (0.96)	23.82 (1.22)	0.62
Vitamin D (μg)	2.69 (2.14)	2.95 (1.85)	0.92
Vitamin C (mg)	74.42 (12.02)	67.29 (7.78)	0.62
Selenium (μg)	0.03 (0.004)	0.07 (0.03)	0.30
B-caroten (μg)	697.30 (113.44)	798.46 (131.13)	0.56
EPA (g)	0.01 (0.005)	0.01 (0.005)	0.96
DHA (g)	0.03 (0.01)	0.57 (0.54)	0.31
Calcium (mg)	552.66 (34.76)	510.89 (69.16)	0.58

Independent-sample t-test; mean ± SD; SD: standard error.